Biotech company news News

Most Popular Biotech company news Story

Patent 'cliff' looms for Big Pharma

May 1, 2007 — 7:01pm ET

A new report says that the next decade will see a sharp spike in the number of generic drugs coming into the $643 billion global pharmaceutical market. Datamonitor says that knockoffs for drugs that earn $140 billion in sales will lose patent protection by 2016. Lipitor will be one of the next …

Read more...

Latest Headlines

Noven expands pipeline with $125M JDS buyout
July 9, 2007
Biotech start-up pockets $8.7M in venture cash
July 9, 2007
Roche harnesses Alnylam's RNAi tech in $1B deal
July 8, 2007
Pfizer, BMS report Phase II clotting trial success
July 8, 2007
BioVex raises $22M for ongoing cancer trial
July 8, 2007
Silence shouts about $400M AstraZeneca deal
July 5, 2007
Genzyme diarrhea drug fails Phase III
July 5, 2007
BMS sees positive outcome for cancer drug
July 5, 2007
Provenge delay triggers furor among cancer victims
July 5, 2007
Florida's $250M development cache threatened
July 5, 2007
Genaera abandons two studies in pipeline switch
July 4, 2007
Genzyme shifts focus after hylastan fails trial
July 4, 2007
Cosmo shares buoyed by successful antibiotic data
July 4, 2007
PDUFA debate highlights drug safety issues
July 4, 2007
Bioenvision shareholders shun Genzyme takeover bid
July 2, 2007
New combos of old drugs may be boon to biotech
July 2, 2007
Par strikes $65M licensing deal for antifungal therapy
July 2, 2007
Novartis pays big for roster of new vaccines
July 1, 2007
Biogen inks $220M deal for Cardiokine drug
July 1, 2007
Medicines Co. pays $45M to reacquire drug rights
July 1, 2007

Paid Research Reports

More Research Reports >>